Results 161 to 170 of about 21,307 (209)
Some of the next articles are maybe not open access.
Comparison of the morbidity of tetanus toxoid boosters with tetanus-diphtheria toxoid boosters
Annals of Emergency Medicine, 1985A double-blind randomized trial was performed to compare the subjective morbidity of tetanus toxoid (T) with that of tetanus-diphtheria toxoid (Td). Symptoms occurred in 46 (48%) of 93 patients who received T, and in 75 of 100 patients who received Td (chi 2 = 12.3; P less than .001).
M B, Macko, C E, Powell
openaire +2 more sources
Allergy to tetanus toxoid vaccine
Allergy, 2001. IGE-MEDIATED hypersensitivity reactions to tetanus toxoid (TT) vaccine are very rare (1/1 000 000) (1); nevertheless, physicians must be prepared to deal with them when administering this agent. We report four cases of IgE-mediated adverse reactions to TT vaccine, as documented by positive serum IgE antibodies to TT and, in two cases also, by a ...
Bellioni Businco B +5 more
openaire +3 more sources
Nationwide Tetanus Toxoid Immunization
JAMA, 1962THE THREAT of tetanus, with its high morbidity and mortality, is ever present. In these days of numerous automobile collisions, burns, the occasional airplane crash, and other accidents, deep wounds occur in which tetanus toxin can be produced. In addition to such nonmilitary accidents, there is now the fearful possibility of nuclear warfare with many ...
W, FURSTE, E, FARNHAM, L C, ROETTIG
openaire +2 more sources
Adverse reactions to tetanus toxoid
The Journal of Trauma: Injury, Infection, and Critical Care, 1982A retrospective review of 740 charts of patients with a history of adverse reaction to tetanus toxoid immunization was undertaken. The most common reactions, by history, were local edema and tenderness (33%), fever (15%), and anaphylactoid response (33%).
R L, Jacobs, R S, Lowe, B Q, Lanier
openaire +2 more sources
Cellular Immunology of Tetanus Toxoid
1995Studies on tetanus neurotoxin (TeNT) as an antigen have been informative at a basic level and are continuing to expand our knowledge of what makes an effective immunogen, and how we might be able to exploit the biochemistry and physiology of antigen-presenting cells (APC) to make yet more effective immunogens. This review deals with two related aspects
Corradin, G., Watts, C.
openaire +4 more sources